These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 7595219)
1. The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire. Scherer MT; Ignatowicz L; Pullen A; Kappler J; Marrack P J Exp Med; 1995 Nov; 182(5):1493-504. PubMed ID: 7595219 [TBL] [Abstract][Full Text] [Related]
2. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules. Simpson E; Takacs K; Altmann DM Thymus; 1994; 23(1):1-13. PubMed ID: 7863543 [TBL] [Abstract][Full Text] [Related]
3. Synchronous deletion of Mtv-superantigen-reactive thymocytes in the CD3(medium/high) CD4(+)CD8(+) subset. Sheard MA; Sharrow SO; Takahama Y Scand J Immunol; 2000 Dec; 52(6):550-4. PubMed ID: 11119259 [TBL] [Abstract][Full Text] [Related]
4. Identification of two V beta 7-specific viral superantigens. Ignatowicz L; Kappler JW; Marrack P; Scherer MT J Immunol; 1994 Jan; 152(1):65-71. PubMed ID: 8254207 [TBL] [Abstract][Full Text] [Related]
5. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus. Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418 [TBL] [Abstract][Full Text] [Related]
6. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. Waanders GA; Shakhov AN; Held W; Karapetian O; Acha-Orbea H; MacDonald HR J Exp Med; 1993 May; 177(5):1359-66. PubMed ID: 8386743 [TBL] [Abstract][Full Text] [Related]
7. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion. Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876 [TBL] [Abstract][Full Text] [Related]
8. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains. Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017 [TBL] [Abstract][Full Text] [Related]
9. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages. Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568 [TBL] [Abstract][Full Text] [Related]
10. I-J revisited: is the I-J genetic restriction in downregulation due to an endogenous superantigen analogous to mammary tumour virus (Mtv)-encoded endogenous superantigen? Asherson GL; Dieli F; Tomonari K Folia Biol (Praha); 1994; 40(6):341-7. PubMed ID: 7589693 [TBL] [Abstract][Full Text] [Related]
11. T cell repertoire and clonal deletion of Mtv superantigen-reactive T cells in mice lacking CD4 and CD8 molecules. Penninger JM; Schilham MW; Timms E; Wallace VA; Mak TW Eur J Immunol; 1995 Jul; 25(7):2115-8. PubMed ID: 7621886 [TBL] [Abstract][Full Text] [Related]
12. V beta 17 T-cell deletion by endogenous mammary tumor virus in wild-type-derived mouse strain. Jouvin-Marche E; Cazenave PA; Voegtle D; Marche PN Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3232-5. PubMed ID: 1314381 [TBL] [Abstract][Full Text] [Related]
13. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection. Chervonsky AV; Golovkina TV; Ross SR; Janeway CA J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520 [TBL] [Abstract][Full Text] [Related]
15. CD4 regulates the efficiency of an endogenous superantigen-induced clonal deletion of TCRV beta 11+ cells in the periphery. Kubo S; Hasegawa A; Hashimoto K; Shimizu C; Kubo M; Tada T; Nakayama T Immunology; 1997 Dec; 92(4):437-46. PubMed ID: 9497484 [TBL] [Abstract][Full Text] [Related]
16. Divergent viral superantigens delete V beta 5+ T lymphocytes. Gollob KJ; Palmer E Proc Natl Acad Sci U S A; 1992 Jun; 89(11):5138-41. PubMed ID: 1317583 [TBL] [Abstract][Full Text] [Related]
17. Influence of viral superantigens on V beta- and V alpha-specific positive and negative selection. Tomonari K; Fairchild S; Rosenwasser OA Immunol Rev; 1993 Feb; 131():131-68. PubMed ID: 8387455 [TBL] [Abstract][Full Text] [Related]
18. Chronic deletion, escape from deletion and activation of mouse mammary tumor virus superantigen-reactive T cells in C57BL/10 mice. Dyson PJ; Elliott JI Eur J Immunol; 1999 May; 29(5):1456-66. PubMed ID: 10359099 [TBL] [Abstract][Full Text] [Related]
19. Rat T cell responses to superantigens. II. Allelic differences in V beta 8.2 and V beta 8.5 beta chains determine responsiveness to staphylococcal enterotoxin B and mouse mammary tumor virus-encoded products. Gold DP; Surh CD; Sellins KS; Schroder K; Sprent J; Wilson DB J Exp Med; 1994 Jan; 179(1):63-9. PubMed ID: 8270884 [TBL] [Abstract][Full Text] [Related]
20. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance. Schirrmacher V; Beutner U; Bucur M; Umansky V; Rocha M; von Hoegen P J Immunol; 1998 Jul; 161(2):563-70. PubMed ID: 9670928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]